Market Overview: The metastatic prostate cancer market is expected to exhibit a CAGR of 6.48% during 2023-2033. The report offers a comprehensive analysis of the metastatic prostate cancer market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in...